NovoCure Limited revenue breakdown overview

NovoCure Limited revenue for the last year amounted to 509.34 M USD, the most of which — 509.34 M USD — came from its highest performing source at the moment, Tumor Treating Fields, the year earlier bringing 537.84 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought NovoCure Limited 349.74 M USD, and the year before that — 406.89 M USD.